Eravacycline Conference Call: Unrevealing and Disappointing
![](https://i0.wp.com/allphasepharma.com/dir/wp-content/uploads/2015/11/Watertown-copy.jpg?resize=640%2C280&ssl=1)
Whatever has become of investigative journalism? All we read after the Stifel conference call (11/17/2015) is descriptive rehash of information provided by Tetraphase at the conference. No probing questions that we thought investors would ask who just lost 80% of Continue reading Eravacycline Conference Call: Unrevealing and Disappointing